While changes in neuromorphology and synaptic loss have been reported in mouse models of ALS-FUS [42, 61, 63], other pathological features of ALS/FTD such as glial activation and protein aggregation coincide with these changes, making it difficult to determine the cell-type contributions to these defects. This evidence concerns the gene FUS and frontotemporal dementia.